HR 6476, the Relief for Farmers Hit with PFAS Act, creates a federal grant program to assist farmers and agricultural communities affected by unsafe levels of PFAS (chemicals used in industrial products) in soil or water. Eligible governments (states, tribes, territories) can receive grants to fund specific actions, including compensating farmers for contaminated land or products, covering health monitoring for affected residents, investing in remediation equipment, conducting PFAS research, and developing educational programs. Grants prioritize direct financial assistance to producers experiencing losses due to contamination and require annual reports on fund usage. The program is authorized with $500 million for fiscal years 2026-2029, targeting communities with PFAS-contaminated agricultural land or water used for farm production.
This bill extends the Affordable Care Act's premium tax credit through 2028 (instead of 2026) and raises the household income eligibility cap from 400% to 700% of the federal poverty level. It allows individuals to receive advance credit payments directly into their Health Savings Accounts (HSAs) or to their insurance issuer, depending on their plan type and election. The bill also establishes a minimum monthly premium responsibility amount for coverage and requires federal agencies to verify immigration status for tax credit eligibility. These changes primarily affect low-to-moderate income individuals purchasing health insurance through the ACA marketplace.
This bill expands a tax credit for companies building facilities that manufacture semiconductors, semiconductor equipment, or semiconductor materials. It clarifies which materials count as qualifying (including direct materials like chip substrates and indirect materials like cleaning chemicals used in production) and extends the credit's deadline from 2026 to 2031. The changes directly affect semiconductor manufacturers investing in new facilities or equipment by making the tax credit more broadly applicable and longer-lasting.
The EGG SAVE Act of 2025 creates a federal tax credit for U.S. commercial egg hatcheries that install equipment to identify the sex of chicken embryos before hatching. The credit covers 50% of qualified equipment costs in 2026, 40% in 2027, and 30% in 2028, provided the equipment achieves at least 95% accuracy. It applies only to equipment purchased, installed, or used in U.S. hatcheries for commercial egg production. The credit expires for property placed in service after December 31, 2028.
HR 6645, the Working Families Disaster Tax Relief Act, allows individuals affected by federally declared disasters to use their *previous year's income* to qualify for the Child Tax Credit and Earned Income Credit. This helps families who lost income due to a disaster (like a hurricane or wildfire) but would qualify for tax credits if their income from the prior year was used instead. The bill amends tax code sections to create a simple election process for "disaster-affected taxpayers" - defined as those whose home or workplace was in a declared disaster zone during the disaster period. It applies to tax years starting after December 31, 2024, and does not change the credit amounts, only the income calculation method for affected individuals.
The Hire Student Veterans Act expands the Work Opportunity Tax Credit to include veterans enrolled in school using educational benefits from VA or military programs (such as the GI Bill). Employers hiring these veterans can claim a tax credit, making it easier to recruit students using benefits under specific VA or military education programs. The bill modifies the minimum employment requirement for these veterans, excluding them from standard work duration rules that apply to other credit-eligible hires. These changes take effect for veterans hired after the bill becomes law.
This bill creates a tax deduction for certain reported cash tips received by workers in occupations that traditionally rely on tips, such as servers and bartenders. It allows a deduction of up to $35,000 per year for tips reported to employers (e.g., via Form 4137), but phases out for individuals earning over $50,000 annually (single) or $100,000 (joint). The deduction requires a Social Security number and applies only to taxable years starting in 2026 through 2028, with a Treasury pilot program to evaluate extending it permanently. It excludes tips from occupations not traditionally tip-based and mandates annual reviews of living wage thresholds.
This bill extends and increases tax credits for sustainable aviation fuel (SAF) producers. It raises the credit rate from 20 cents to 35 cents per gallon for certain SAF facilities and from $1.00 to $1.75 per gallon for others, while requiring SAF to meet ASTM International standards and exclude palm oil or petroleum-derived sources. The credit period is extended from ending in 2029 to 2033, applying to fuel produced after December 31, 2025. The bill directly affects SAF producers meeting these specific criteria, aiming to incentivize cleaner fuel production for the aviation industry.
The Increasing Baseline Updates Act requires the Congressional Budget Office to provide at least two annual updates to the budget baseline for Congress's Budget Committees, including the economic data used in those updates. It also mandates that the President submit detailed technical budget data to Congress by February 1 each year, featuring current and prior year budget figures and credit reestimates. These provisions update the annual reporting requirements for the Congressional Budget Office and the President's office. The bill directly affects how Congress receives timely budget information for fiscal planning.
The Biomanufacturing Excellence Act of 2025 establishes a National Biopharmaceutical Manufacturing Center of Excellence under the National Institute of Standards and Technology (NIST). It authorizes $120 million in funding for fiscal year 2026 to competitively award a grant to eligible entities - such as public-private partnerships, universities, or consortia - to create this center. The center will advance biopharmaceutical manufacturing technology, strengthen U.S. supply chains for medicines, and develop workforce training programs, with a focus on products critical to national security, health, and economic security. It requires annual progress reports to Congress and mandates the center to collaborate with manufacturers, research institutions, and educational partners to scale innovative production methods.
